Phase II Study of Irinotecan (CPT 11) and Cisplatin (CDDP) in Metastatic or Locally Advanced Penile Carcinoma

Trial Profile

Phase II Study of Irinotecan (CPT 11) and Cisplatin (CDDP) in Metastatic or Locally Advanced Penile Carcinoma

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Jun 2016

At a glance

  • Drugs Irinotecan (Primary) ; Cisplatin
  • Indications Penile cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Jul 2009 United Kingdom Clinical Research Network reports accrual to date as 132%; this was identified via CA tool on 15 Jul 2009.
    • 15 Jul 2009 New source identified and integrated (United Kingdom Clinical Research Network, 1004)
    • 06 Feb 2009 Additional location (Netherland) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top